Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Treating Hair Loss in Transgender Patients
Description
Dr. AS Sigal discusses the treatment of hair loss in transgender patients, highlighting differences between trans men and trans women. For trans men, testosterone is the primary hormone that regulates hair growth and is used for masculinization. Treatments such as minoxidil, low light laser therapy, and finasteride are recommended, though finasteride usage is controversial as it may block certain masculinizing physical changes if given too early. It's advised to start finasteride only after two years of testosterone therapy. In trans women, the use of estrogens and anti-androgens like spironolactone aims to promote feminization while potentially impacting hair distribution. Non-hormonal treatments for trans women mirror those used for men, with an emphasis on topical minoxidil, low light therapy, and hormonal support. The presentation concludes with an invitation to a congress focusing on these issues, emphasizing the importance of tailored approaches in treating hair loss for transgender individuals.
View moreConclusions
- Hair loss treatments for transgender patients should consider individual hormonal regimens and potential interactions with treatments.
- Trans men can use non-hormonal treatments like minoxidil and low light laser therapy without interactions with gender affirming hormones.
- Oral finasteride use in trans men is controversial, and should only be considered after two years of testosterone therapy to prevent blocking desired secondary sex characteristics.
- For trans women, estrogen therapy can reverse scalp hair loss and reduce facial and body hair growth.
- Both trans men and trans women may benefit from topical or oral minoxidil as a first line treatment for androgenetic alopecia.
- Second line treatments for trans men may include finasteride, dutasteride, PRP, and hair transplant, depending on individual needs and results from first line treatments.
- Trans women may also utilize antiandrogens like spironolactone and bicalutamide in conjunction with estrogen therapy for hair loss management.
- Hair loss in transgender patients involves complex hormonal interactions that necessitate personalized treatment plans.
- Long-term hormonal therapy plays a crucial role in the effectiveness of hair loss treatments for transgender individuals.
- Am J Clin Dermatol. 2018;19(4):517-527. Gao Y, Maurer T, Paradi Mirmirani P. Understanding and Addressing Hair Disorders in Transgender Individuals
- Gao JL, Streed CG Jr, Thompson J, Dommasch ED, Peebles JK. Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics. J Am Acad Dermatol. 2021:S0190-9622(21)02574-3
- Moreno-Arrones OM, Becerra A, Vano-Galvan S. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients. Clin Exp Dermatol. 2017;42(7):743-748.
- Stevenson MO, Wixon N, Safer JD. Scalp Hair Regrowth in Hormone-Treated Transgender Woman. Transgend Health. 2016;1(1):202-204.